Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes, 38116-38117 [2011-16218]

Download as PDF 38116 Federal Register / Vol. 76, No. 125 / Wednesday, June 29, 2011 / Notices Any party having a substantial interest in these proceedings may request a public hearing on the matter. A written request for a hearing must be submitted to the Trade Adjustment Assistance for Firms Division, Room 7106, Economic Development Administration, U.S. Department of Commerce, Washington, DC 20230, no later than ten (10) calendar days following publication of this notice. Please follow the requirements set forth in EDA’s regulations at 13 CFR 315.9 for procedures to request a public hearing. The Catalog of Federal Domestic Assistance official number and title for the program under which these petitions are submitted is 11.313, Trade Adjustment Assistance for Firms. Dated: June 23, 2011. Sunni Massey, Eligibility Certifier. [FR Doc. 2011–16329 Filed 6–28–11; 8:45 am] BILLING CODE 3510–WH–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [Doc. 10–2011] mstockstill on DSK4VPTVN1PROD with NOTICES Foreign-Trade Zone 274, Butte, Montana, Manufacturing Authority, REC Silicon, (Polysilicon and Silane Gas); Notice of Approval On February 11, 2011, an application was submitted by the City and County of Butte-Silver Bow, grantee of ForeignTrade Zone (FTZ) 274, requesting authority on behalf of REC Silicon to manufacture polysilicon and silane gas under FTZ procedures within Site 1 of FTZ 274 in Butte, Montana. The request was given notice in the Federal Register inviting public comment (Docket 10– 2011, 76 FR 9320, 2/17/2011). Section 400.32(b)(1)(i) of the FTZ Board’s regulations (15 CFR part 400) allows the Assistant Secretary for Import Administration to act for the Board in making decisions on new manufacturing authority when the activity is the same, in terms of products involved, to activity recently approved by the Board and similar in circumstances. Pursuant to that regulatory provision, on June 22, 2011, the Assistant Secretary for Import Administration approved authority for REC Silicon’s manufacturing activity, subject to the FTZ Act (19 U.S.C. 81a– 81u) and the Board’s regulations, including Section 400.28, and further subject to a restriction prohibiting the admission of foreign status silicon metal subject to an antidumping or countervailing duty order. VerDate Mar<15>2010 17:48 Jun 28, 2011 Jkt 223001 Dated: June 22, 2011. Andrew McGilvray Executive Secretary. [FR Doc. 2011–16335 Filed 6–28–11; 8:45 am] BILLING CODE ;P CONSUMER PRODUCT SAFETY COMMISSION Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes Consumer Product Safety Commission. ACTION: Notice of meeting. AGENCY: The U.S. Consumer Product Safety Commission (‘‘CPSC’’ or ‘‘Commission’’) announces the fifth meeting of the Chronic Hazard Advisory Panel (CHAP) on phthalates and phthalate substitutes. The Commission appointed this CHAP to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles, pursuant to section 108 of the Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110–314). DATES: The meeting will be held on Monday, July 25, 2011, and Tuesday, July 26, 2011. The meeting will begin at approximately 8 a.m. on both days. It will end at approximately 5 p.m. on Monday and at approximately 3 p.m. on Tuesday. ADDRESSES: The meeting will be held in the fourth floor hearing room at the Commission’s offices at 4330 East West Highway, Bethesda, MD. REGISTRATION AND WEBCAST: Members of the public who wish to attend the meeting may register onsite on the day of the meeting. This meeting will also be available live via Webcast at https:// www.cpsc.gov/Webcast. Registration is not necessary to view the Webcast. There will not be any opportunity for public participation at this meeting. FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health Sciences, U.S. Consumer Product Safety Commission, Bethesda, MD 20814; telephone (301) 504–7253; e-mail mbabich@cpsc.gov. SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently prohibits the sale of any ‘‘children’s toy or child care article’’ containing more than 0.1 percent of each of three specified phthalates—di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits, on an interim basis, the sale of any ‘‘children’s toy that can be placed in a child’s SUMMARY: PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 mouth’’ or ‘‘child care article’’ containing more than 0.1 percent of each of three additional phthalates— diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate (DNOP). Moreover, section 108 of the CPSIA requires the Commission to convene a CHAP ‘‘to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles.’’ The CPSIA requires the CHAP to complete an examination of the full range of phthalates that are used in products for children and: • Examine all of the potential health effects (including endocrine disrupting effects) of the full range of phthalates; • Consider the potential health effects of each of these phthalates, both in isolation and in combination with other phthalates; • Examine the likely levels of children’s, pregnant women’s, and others’ exposure to phthalates, based upon a reasonable estimation of normal and foreseeable use and abuse of such products; • Consider the cumulative effect of total exposure to phthalates, from children’s products and from other sources, such as personal care products; • Review all relevant data, including the most recent, best available, peerreviewed, scientific studies of these phthalates and phthalate alternatives that employ objective data-collection practices or employ other objective methods; • Consider the health effects of phthalates not only from ingestion but also as a result of dermal, hand-tomouth, or other exposure; • Consider the level at which there is a reasonable certainty of no harm to children, pregnant women, or other susceptible individuals and their offspring, reviewing the best available science, and using sufficient safety factors to account for uncertainties regarding exposure and susceptibility of children, pregnant women, and other potentially susceptible individuals; and • Consider possible similar health effects of phthalate alternatives used in children’s toys and child care articles. The CPSIA contemplates completion of the CHAP’s examination within 18 months of the panel’s appointment. The CHAP must review prior work on phthalates by the Commission, but the prior work is not to be considered determinative because the CHAP’s examination must be conducted de novo. The CHAP must make recommendations to the Commission about which phthalates, or E:\FR\FM\29JNN1.SGM 29JNN1 Federal Register / Vol. 76, No. 125 / Wednesday, June 29, 2011 / Notices combinations of phthalates (in addition to those identified in section 108 of the CPSIA), or phthalate alternatives that the panel determines should be prohibited from use in children’s toys or child care articles or otherwise restricted. The Commission selected the CHAP members from scientists nominated by the National Academy of Sciences. See 15 U.S.C. 2077, 2030(b). The CHAP met previously in April, July, and December 2010, and in March 2011. The CHAP heard testimony from interested parties at the July 2010 meeting. The July 2011 meeting will include discussion of the CHAP’s progress in its analysis of potential risks from phthalates and phthalate substitutes. There will not be any opportunity for public comment at the July 25–26, 2011 meeting. Dated: June 23, 2011. Todd A. Stevenson, Secretary. [FR Doc. 2011–16218 Filed 6–28–11; 8:45 am] BILLING CODE 6355–01–P CONSUMER PRODUCT SAFETY COMMISSION Commission Agenda and Priorities; Notice of Hearing U.S. Consumer Product Safety Commission. ACTION: Notice of public hearing. AGENCY: The U.S. Consumer Product Safety Commission (‘‘Commission’’) will conduct a public hearing to receive views from all interested parties about its agenda and priorities for fiscal year 2013, which begins on October 1, 2012. Participation by members of the public is invited. Written comments and oral presentations concerning the Commission’s agenda and priorities for fiscal year 2013 will become part of the public record. DATES: The hearing will begin at 10 a.m. on July 20, 2011. Requests to make oral presentations and the written text of any oral presentations must be received by the Office of the Secretary not later than 5 p.m. Eastern Standard Time (‘‘E.S.T.’’) on July 15, 2011. ADDRESSES: The hearing will be in the Hearing Room, 4th Floor of the Bethesda Towers Building, 4330 East West Highway, Bethesda, Maryland 20814. Requests to make oral presentations and texts of oral presentations should be captioned ‘‘Agenda and Priorities FY 2013’’ and sent by electronic mail (‘‘email’’) to cpsc-os@cpsc.gov, or mailed or delivered to the Office of the Secretary, U.S. Consumer Product Safety mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:48 Jun 28, 2011 Jkt 223001 Commission, 4330 East West Highway, Bethesda, Maryland 20814, no later than 5 p.m. E.S.T. on July 15, 2011. DEPARTMENT OF DEFENSE For information about the hearing or to request an opportunity to make an oral presentation, please send an e-mail, call, or write Todd A. Stevenson, Office of the Secretary, Consumer Product Safety Commission, 4330 East West Highway, Bethesda, Maryland 20814; e-mail cpscos@cpsc.gov; telephone (301) 504–7923; facsimile (301) 504–0127. An electronic copy of the CPSC’s budget request for fiscal year 2012 can be found at https://www.cpsc.gov/cpscpub/pubs/ reports/2012plan.pdf. 38117 [Docket ID DOD–2011–OS–0069] FOR FURTHER INFORMATION CONTACT: Section 4(j) of the Consumer Product Safety Act (‘‘CPSA’’) (15 U.S.C. 2053(j)) requires the Commission to establish an agenda for action under the laws it administers and, to the extent feasible, to select priorities for action at least 30 days before the beginning of each fiscal year. Section 4(j) of the CPSA provides further that before establishing its agenda and priorities, the Commission conduct a public hearing and provide an opportunity for the submission of comments. Persons who desire to make oral presentations at the hearing on July 20, 2011, should send an e-mail, call, or write Todd A. Stevenson, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, Maryland 20814, email cpsc-os@cpsc.gov, telephone (301) 504–7923, facsimile (301) 504–0127 not later than 5 p.m. E.S.T. on July 15, 2011. Presentations should be limited to approximately 10 minutes. Persons desiring to make presentations must submit the text of their presentations to the Office of the Secretary not later than 5 p.m. E.S.T. on July 15, 2011. The Commission reserves the right to impose further time limitations on all presentations and further restrictions to avoid duplication of presentations. The hearing will begin at 10 a.m. on July 20, 2011, and will conclude the same day. SUPPLEMENTARY INFORMATION: Dated: June 24, 2011. Todd A. Stevenson, Secretary, Consumer Product Safety Commission. [FR Doc. 2011–16235 Filed 6–28–11; 8:45 am] BILLING CODE 6355–01–P PO 00000 Frm 00010 Fmt 4703 Sfmt 4703 Office of the Secretary Notice of Intent To Prepare an Environmental Assessment Regarding DLA Energy’s Mobility Fuel Purchasing Programs Defense Logistics Agency Energy (DLA Energy), DoD. ACTION: Notice of Intent To Prepare an Environmental Assessment Regarding DLA Energy’s Mobility Fuel Purchasing Programs. AGENCY: The Defense Logistics Agency is America’s combat logistics support agency responsible for sourcing and providing nearly every consumable item used by U.S. military forces worldwide. DLA Energy is a primary level field activity of DLA responsible for providing the Department of Defense and other government agencies with comprehensive energy solutions in the most effective and efficient manner possible. Its products and services offer a large array of energy related needs for the Federal Government and also help facilitate the cycle of storage and deployment of fuels and other energy sources. DLA Energy’s action, to purchase mobility fuels for the Department of Defense, has not changed. However, the nature and makeup of the petroleum market has. Crude oil from Canada represents 13% of total United States consumption. The Canadian Association of Petroleum Producers 2010 forecast states that by 2020 Canadian oil sands production will rise from 2.72 million barrels per day in 2009 to 4.34 million barrels per day in 2025. In addition, within the past three years, the Department of State has approved two new pipelines to transport crude oil derived from Canadian oil sands to the United States. An additional permit for a third pipeline is pending. Thus, more petroleum products derived from Canadian oil sands recovered crude may be available within the United States petroleum market. In addition, because various types of crudes are comingled prior to processing and because refined petroleum products are fungible, it is anticipated that these petroleum products produced from Canadian oil sands recovered crude will be blended with and thus indistinguishable from other petroleum products, thereby making it difficult for DLA Energy to exclude Canadian oil sands recovered crude refined petroleum from routine petroleum purchases. Therefore, DLA Energy has decided to study whether its SUMMARY: E:\FR\FM\29JNN1.SGM 29JNN1

Agencies

[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Pages 38116-38117]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16218]


=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION


Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates 
and Phthalate Substitutes

AGENCY: Consumer Product Safety Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Consumer Product Safety Commission (``CPSC'' or 
``Commission'') announces the fifth meeting of the Chronic Hazard 
Advisory Panel (CHAP) on phthalates and phthalate substitutes. The 
Commission appointed this CHAP to study the effects on children's 
health of all phthalates and phthalate alternatives as used in 
children's toys and child care articles, pursuant to section 108 of the 
Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110-
314).

DATES: The meeting will be held on Monday, July 25, 2011, and Tuesday, 
July 26, 2011. The meeting will begin at approximately 8 a.m. on both 
days. It will end at approximately 5 p.m. on Monday and at 
approximately 3 p.m. on Tuesday.

ADDRESSES: The meeting will be held in the fourth floor hearing room at 
the Commission's offices at 4330 East West Highway, Bethesda, MD.

REGISTRATION AND WEBCAST: Members of the public who wish to attend the 
meeting may register onsite on the day of the meeting. This meeting 
will also be available live via Webcast at https://www.cpsc.gov/Webcast. 
Registration is not necessary to view the Webcast.
    There will not be any opportunity for public participation at this 
meeting.

FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health 
Sciences, U.S. Consumer Product Safety Commission, Bethesda, MD 20814; 
telephone (301) 504-7253; e-mail mbabich@cpsc.gov.

SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently 
prohibits the sale of any ``children's toy or child care article'' 
containing more than 0.1 percent of each of three specified 
phthalates--di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate 
(DBP), and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also 
prohibits, on an interim basis, the sale of any ``children's toy that 
can be placed in a child's mouth'' or ``child care article'' containing 
more than 0.1 percent of each of three additional phthalates--
diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-
octyl phthalate (DNOP).
    Moreover, section 108 of the CPSIA requires the Commission to 
convene a CHAP ``to study the effects on children's health of all 
phthalates and phthalate alternatives as used in children's toys and 
child care articles.'' The CPSIA requires the CHAP to complete an 
examination of the full range of phthalates that are used in products 
for children and:
     Examine all of the potential health effects (including 
endocrine disrupting effects) of the full range of phthalates;
     Consider the potential health effects of each of these 
phthalates, both in isolation and in combination with other phthalates;
     Examine the likely levels of children's, pregnant women's, 
and others' exposure to phthalates, based upon a reasonable estimation 
of normal and foreseeable use and abuse of such products;
     Consider the cumulative effect of total exposure to 
phthalates, from children's products and from other sources, such as 
personal care products;
     Review all relevant data, including the most recent, best 
available, peer-reviewed, scientific studies of these phthalates and 
phthalate alternatives that employ objective data-collection practices 
or employ other objective methods;
     Consider the health effects of phthalates not only from 
ingestion but also as a result of dermal, hand-to-mouth, or other 
exposure;
     Consider the level at which there is a reasonable 
certainty of no harm to children, pregnant women, or other susceptible 
individuals and their offspring, reviewing the best available science, 
and using sufficient safety factors to account for uncertainties 
regarding exposure and susceptibility of children, pregnant women, and 
other potentially susceptible individuals; and
     Consider possible similar health effects of phthalate 
alternatives used in children's toys and child care articles.
    The CPSIA contemplates completion of the CHAP's examination within 
18 months of the panel's appointment. The CHAP must review prior work 
on phthalates by the Commission, but the prior work is not to be 
considered determinative because the CHAP's examination must be 
conducted de novo.
    The CHAP must make recommendations to the Commission about which 
phthalates, or

[[Page 38117]]

combinations of phthalates (in addition to those identified in section 
108 of the CPSIA), or phthalate alternatives that the panel determines 
should be prohibited from use in children's toys or child care articles 
or otherwise restricted. The Commission selected the CHAP members from 
scientists nominated by the National Academy of Sciences. See 15 U.S.C. 
2077, 2030(b).
    The CHAP met previously in April, July, and December 2010, and in 
March 2011. The CHAP heard testimony from interested parties at the 
July 2010 meeting. The July 2011 meeting will include discussion of the 
CHAP's progress in its analysis of potential risks from phthalates and 
phthalate substitutes. There will not be any opportunity for public 
comment at the July 25-26, 2011 meeting.

    Dated: June 23, 2011.
Todd A. Stevenson,
Secretary.
[FR Doc. 2011-16218 Filed 6-28-11; 8:45 am]
BILLING CODE 6355-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.